Cytoplasmic-anti-neutrophil cytoplasmic antibodies targeting myeloperoxidase in Wegener's granulomatosis: A rare phenomenon.

dc.contributor.authorVenkatesh, Bhavana M
dc.contributor.authorJoshi, Sangeeta
dc.contributor.authorAdhikary, Ranjeeta
dc.date.accessioned2015-02-16T09:17:10Z
dc.date.available2015-02-16T09:17:10Z
dc.date.issued2014-07
dc.description.abstractWegener’s granulomatosis (WG) patients can rarely have antineutrophil cytoplasmic antibodies (ANCAs) directed against myeloperoxidase (MPO), producing a cytoplasmic pattern on indirect immunofluorescence (IIF). This has important implications in the diagnosis and pathophysiology of the disease. We present to you a report of three cases of WG, demonstrating a cytoplasmic- ANCA pattern on indirect IIF, but directed against MPO. It is necessary to diagnose a patient taking into account both the autoimmune test results and the clinical features.en_US
dc.identifier.citationVenkatesh Bhavana M, Joshi Sangeeta, Adhikary Ranjeeta. Cytoplasmic-anti-neutrophil cytoplasmic antibodies targeting myeloperoxidase in Wegener's granulomatosis: A rare phenomenon. Indian Journal of Pathology & Microbiology. 2014 Jul-sept 57 (3): 470-472.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/156090
dc.language.isoenen_US
dc.source.urihttps://www.ijpmonline.org/article.asp?issn=0377-4929;year=2014;volume=57;issue=3;spage=470;epage=472;aulast=Venkateshen_US
dc.subjectCytoplasmic antineutrophil cytoplasmic antibodiesen_US
dc.subjectimmunofluorescenceen_US
dc.subjectmyeloperoxidaseen_US
dc.subjectWegener’s granulomatosisen_US
dc.titleCytoplasmic-anti-neutrophil cytoplasmic antibodies targeting myeloperoxidase in Wegener's granulomatosis: A rare phenomenon.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijpm2014v57n3p470.pdf
Size:
373.33 KB
Format:
Adobe Portable Document Format
Description:
Case report
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: